Virologic Failure of High-Dose Raltegravir With Concomitant Rifampin

    loading  Checking for direct PDF access through Ovid


Treating mycobacterial infections and HIV concurrently typically presents difficulties due to drug-to-drug interactions between rifampin and many antiretrovirals. We present a case of raltegravir failure during concomitant rifampin use, despite documented administration of recommended increased dose of raltegravir.

    loading  Loading Related Articles